secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEKTAR THERAPEUTICS (NKTR)
CIK:        0000906709
Form:       8-K
Filed at:   2024-02-16T23:59:59+00:00
Accession:  0001213900-24-014968
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.02, 1.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nektar repurchases 8.28M shares from BMS for $3M; reduces outstanding shares by 4.34%
--------------------------------------------------------------------------------

- Purchased 8,284,600 BMS-held restricted shares for $3,000,000 aggregate.
- Stock repurchase reduces outstanding shares by ~4.34% based on Nov 2023 10-Q count.
- 2018 Share Purchase Agreement and Investor Agreement with BMS terminated.
- Reduction reflected in weighted-average shares for quarter ending June 30, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/906709/000121390024014968/0001213900-24-014968-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/906709/000121390024014968/ea190567-8k_nektarther.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-014968

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer